<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000648584"><TermName>anti-PDGFR alpha monoclonal antibody IMC-3G3</TermName><TermPronunciation>(AN-tee … AL-fuh MAH-noh-KLOH-nul AN-tee-BAH-dee …)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of glioblastoma (a type of brain tumor) that has come back. It binds to receptors for a protein called platelet-derived growth factor (PDGF). This keeps PDGF from binding to the cells. This may stop the growth of cancer cells and blood vessels that have the receptors for PDGF. It is a type of monoclonal antibody. Also called anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3 and IMC-3G3.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726145" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anti-PDGFR alpha monoclonal antibody IMC-3G3&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726144" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anticuerpo monoclonal alfa IMC-3G3 anti-RFCDP&quot;" language="es" id="_4"/><SpanishTermName>anticuerpo monoclonal alfa IMC-3G3 anti-RFCDP</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de glioblastoma (un tipo de tumor cerebral) que volvió. Se une con los receptores de una proteína que se llama factor de crecimiento derivado de plaquetas (FCDP). Esto impide que el FCDP se una a las células.   Puede detener el crecimiento de las células cancerosas y los vasos sanguíneos que tienen receptores para el FCDP. Es un tipo de anticuerpo monoclonal.   También se llama anticuerpo monoclonal alfa IMC-3G3 anti-receptor del factor de crecimiento derivado de plaquetas y IMC-3G3.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-01-11</DateFirstPublished></GlossaryTerm>
